Healio
Healio
an image of a red lung against a blue background with text reading Take Homes in Lung Cancer

Take Homes in Lung Cancer
ByJae Y. Kim, MD
ByMarley V. Ghizzone

Read more

September 28, 2021
2 min watch
Save

VIDEO: NADIM study update may reposition neoadjuvant therapy for advanced NSCLC

ByJae Y. Kim, MD
ByMarley V. Ghizzone

In this video, Jae Y. Kim, MD, highlights updated data from the NADIM trial presented at the International Association for the Study of Lung Cancer World Conference on Lung Cancer.

According to Kim, chief of thoracic surgery and associate professor at City of Hope, the 3-year overall survival in both the intent-to-treat and per-protocol populations were “really amazing for patients with stage III disease.”

Reference:

  • Provencio M, et al. Abstract OA20.01. Presented at: International Association for the Study of Lung Cancer World Conference on Lung Cancer (virtual meeting); Sept. 8-14, 2021.
Sources/Disclosures

Collapse
Source: Healio Interview
Disclosures: Kim reports receiving a research grant to his institution from Eli Lily and serving as a consultant for AstraZeneca.

Read more about

neoadjuvant therapy
nivolumab
city of hope
non-small cell lung cancer
 

Related Content